.png){kind=icon}
.png){kind=icon}
Return
Baseline Neuroinflammation Stratifies TSPO-PET Response to Disease-Modifying Therapy in Multiple Sclerosis
.png){kind=icon}
OA
AI
M
M
G
M
M
L
DOI：10.1002/acn3.70472.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
To investigate which baseline clinical and imaging characteristics best predict TSPO-PET-measurable reduction in glial activation following treatment of multiple sclerosis (MS), to utilize this information for designing more efficient biomarker-based clinical trials targeting glial activation.
Keywords:
DMT
microglial activation
multiple sclerosis
predictive biomarker
TSPO-PET
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
3.9
Papers:
2.6K
Citations:
7.4K
Organization
Cited Papers